Skip to main navigation Skip to search Skip to main content

Efficacy and Safety of Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) for the Treatment of Relapsed and Refractory AL Amyloidosis

  • Eyal Lebel
  • , Nathalie Asherie
  • , Miri Assayag
  • , Shlomo Elias
  • , Sigal Grisariu
  • , Batia Avni
  • , Shlomit Kfir-Erenfeld
  • , Tali Dubnikov-Sharon
  • , Rivka Alexander-Shani
  • , Nomi Bessig
  • , Alaa Shehadeh
  • , Aseel Ishtay
  • , Shelly Pimienta
  • , Vladimir Vaistein
  • , Eran Zimran
  • , Marjorie Pick
  • , Yael C. Cohen
  • , Irit Avivi Mazza
  • , Cyrille Cohen
  • , Polina Stepensky
  • Moshe E. Gatt

Research output: Contribution to journal › Meeting Abstract › peer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)894-895
Number of pages2
JournalBlood
Volume144
DOIs
StatePublished - 5 Nov 2024

Cite this